[1]张佳胤.核素心肌显像在冠状动脉旁路移植术中的应用[J].国际放射医学核医学杂志,2005,29(4):152-154.
 ZHANG Jia-yin.Application of nuclear myocardial imaging in coronary artery bypass graft[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):152-154.
点击复制

核素心肌显像在冠状动脉旁路移植术中的应用(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
29
期数:
2005年第4期
页码:
152-154
栏目:
核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Application of nuclear myocardial imaging in coronary artery bypass graft
作者:
张佳胤
200025 上海, 上海第二医科大学瑞金医院核医学科
Author(s):
ZHANG Jia-yin
Department of Nuclear Medicine, The Third Hospital Affiliated to Suzhou University, Changzhou 213003, China
关键词:
存活心肌核素显像冠状动脉旁路移植术冠心病
Keywords:
myocardial viabilitypositron emission tomographycoronary artery bypass graftcoronary artery disease
分类号:
R817.4
摘要:
心肌存活的判断对于严重冠心病患者选择再血管化适应证、估测疗效和判断预后有着极其重要的临床意义。传统的201Tl静息-再分布显像能较好又经济地评估心肌活力,门控显像技术显示的室壁运动情况能帮助医师更准确地判断缺血心肌的活力,18F-氟代脱氧葡萄糖(18F-FDG)心肌代谢显像是迄今评估心肌活力最准确的方法。患者在冠状动脉旁路移植术后出现胸闷症状时,核素心肌显像也能准确地判断有无新发缺血灶或是原有病变术后再狭窄。
Abstract:
The assessment of myocardial viability is clinically significant for doctors in determining which patient to undergo coronary artery bypass graft (CABG), and pridicting the sugery effect and prognosis as well. 201T1 rest/redistribution imaging can effectively and economically assess the myocardial viability, The gated SPECT imaging can provide the motion information of the myocardium which enhance the sensitivity and specificity in evaluating the myocardial viability in some equivocal cases. 18F-FDG myocardial metabolic imaging combined with myocardial perfusion imaging still remain as the "Golden Standard" in assessing the myocardial viability. Besides, myocardial perfusion imaging can effectively distinguish the re-stenosis from new coronary arterial stenosis in post-CABG patients with angina symptoms.

参考文献/References:

1 周前.中华影像医学,影像核医学卷[M].北京:人民卫生出版社,2002.71-72.
2 Bonow RO, Dilsizian V, Cuocolo A, et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-Fluorodeoxyglucose[J]. Circulation, 1991, 83(1):26-37.
3 Pirich C, Schwaiger M. The clinical role of positron emission tomography in management of the cardiac patient[J]. Rev Port Cardiol,2000, 19(Suppl 1):89-100.
4 Barrington SF, Chambers J, Hallett WA, et al. Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium[J]. Eur J Nucl Med Mol Imaging, 2004, 31(3):355-361.
5 Sloof GW, Knapp FF Jr, van Lingen A, et al. Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography[J]. Nucl Med Commun, 2003, 24(4):375-381.
6 Schmidt M, Voth E, Schneider CA, et al. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization[J]. Magn Reson Imaging, 2004, 22(2):229-236.
7 李殿富.核素显像识别存活心肌的临床应用进展[J].国外医学·放射医学核医学分册,2003,27(3):104-106.
8 Liao L, Cabell CH, Jollis JG, et al. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization[J].Am J Cardiol, 2004, 93(10):1275-1279.
9 Mabuchi M, Kubo N, Morita K, et al. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT[J]. Nucl Med Commun, 2003, 24(6):625-631.
10 Blinder G, Benhorin J, Koukoui D, et al. The value of electrocardiography-gated multi-slice computed tomography in the evaluation of patients with chest pain [J]. Isr Med Assoc J, 2005, 7(7):419-423.
11 Schlosser T, Konorza T, Hunold P, et al. Noninvasive visualization of coronary artery bypass grafts using 16-detector row computed tomography[J]. J Am Coll Cardiol, 2004, 44(6):1224-1229.
12 Fayad ZA. MR imaging for the noninvasive assessment of atherothrombotic plaques[J]. Magn Reson Imaging Clin N Am, 2003, 11(1): 101-113.
13 Watanuki A, Yoshino H, Udagawa H, et al. Quantitative evaluation of coronary stenosis by coronary magnetic resonance angiography[J]. Heart Vessels, 2000, 15(4):159-166.

相似文献/References:

[1]靳彩玲,范我.99Tcm-AnnexinV用于体内细胞凋亡显像的研究进展[J].国际放射医学核医学杂志,2005,29(1):23.
 JIN Cai-ling,FAN Wo.Advance of apoptosis imaging with 99Tcm labeled Annexin V[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):23.
[2]刘晓梅,李冬雪,潘莉萍.核医学对放疗诱发的肾、脑、唾液腺等正常组织损伤的监测[J].国际放射医学核医学杂志,2005,29(4):166.
 LIU Xiao-mei,LI Dong-xue,PAN Li-ping.Nuclear medicine in the detection of radiation associated normal tissue damage of kidney, brain and salivary glands[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):166.
[3]陈璟,吴华.核素炎症显像的研究进展[J].国际放射医学核医学杂志,2003,27(3):107.
 CHEN Jing,WU Hua.The development of radionuclide imaging of infection and inflammation[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):107.
[4]何薇,蒋茂松.核素炎症定位显像在炎症性肠道疾病中的临床应用[J].国际放射医学核医学杂志,2001,25(1):3.
 HE Wei.Clinical evaluation of radiopharmaceuticals for the inflammatory localization of Crohn’s disease and ulcerative colitis[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):3.
[5]朱小华.99Tcm标记annexin V进行体内凋亡显像的研究[J].国际放射医学核医学杂志,2000,24(2):51.
 ZHU Xiao-hua.The study about imaging of apoptosis with 99Tcm-labled annexin V[J].International Journal of Radiation Medicine and Nuclear Medicine,2000,24(4):51.
[6]罗锡圭.消化系统疾病核素检查的临床价值[J].国际放射医学核医学杂志,1998,22(1):17.
[7]陈璟,吴华.核素显像在乳腺癌诊治中的应用进展[J].国际放射医学核医学杂志,1998,22(6):252.
[8]马寄晓.甲状旁腺的核素显像[J].国际放射医学核医学杂志,1997,21(5):268.
[9]黄钢,赵惠杨.PET心肌代谢显像评价心肌梗塞区存活心肌[J].国际放射医学核医学杂志,1995,19(6):241.
[10]李殿富.核素显像识别存活心肌的临床应用进展[J].国际放射医学核医学杂志,2003,27(3):105.
 LI Dian-fu.Clinical advances of nuclear imaging in the assessment of viable myocardium[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):105.

备注/Memo

备注/Memo:
收稿日期:2004-11-24。
更新日期/Last Update: 1900-01-01